Corbenic Partners LLC - REXAHN PHARMACEUTICALS INC ownership

REXAHN PHARMACEUTICALS INC's ticker is RNN and the CUSIP is 761640101. A total of 36 filers reported holding REXAHN PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Corbenic Partners LLC ownership history of REXAHN PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2017$1,0001,6000.0%0.00%
Q4 2016$01,6000.0%0.00%
Q3 2016$01,6000.0%0.00%
Q2 2016$0
-100.0%
1,6000.0%0.00%
-100.0%
Q1 2016$1,0000.0%1,6000.0%0.00%0.0%
Q4 2015$1,0000.0%1,6000.0%0.00%0.0%
Q3 2015$1,0000.0%1,6000.0%0.00%0.0%
Q2 2015$1,0000.0%1,6000.0%0.00%0.0%
Q1 2015$1,0000.0%1,6000.0%0.00%0.0%
Q4 2014$1,0000.0%1,6000.0%0.00%0.0%
Q3 2014$1,0000.0%1,6000.0%0.00%0.0%
Q2 2014$1,000
-50.0%
1,6000.0%0.00%
-50.0%
Q1 2014$2,0001,6000.00%
Other shareholders
REXAHN PHARMACEUTICALS INC shareholders Q1 2014
NameSharesValueWeighting ↓
Northeast Financial Consultants Inc 150,000$109,0000.05%
CONDOR CAPITAL MANAGEMENT 211,371$154,0000.04%
Benin Management CORP 83,000$61,0000.03%
First Heartland Consultants, Inc. 20,000$15,0000.01%
Advisory Services Network, LLC 22,000$16,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 180,000$131,0000.00%
Moors & Cabot, Inc. 11,000$7,0000.00%
TCI Wealth Advisors, Inc. 3,000$2,0000.00%
Corbenic Partners LLC 1,600$1,0000.00%
WFG Advisors, LP 3,500$3,0000.00%
View complete list of REXAHN PHARMACEUTICALS INC shareholders